These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis]. Saito W, Nagayama N, Miyamoto M, Hara H, Suzuki J, Masuda K, Baba M, Tamura A, Nagai H, Akagawa S, Kawabe Y, Machida K, Kurashima A, Yotsumoto H. Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568 [Abstract] [Full Text] [Related]
4. Microscopic examination and treatment outcomes of new pulmonary tuberculosis cases in Istanbul dispensaries between 1998 and 2000. Kílícaslan Z, Oztürk F, Sarimurat N, Cuhadaroglu C, Caglar E, Erem A. Int J Tuberc Lung Dis; 2003 Nov; 7(11):1059-63. PubMed ID: 14598965 [Abstract] [Full Text] [Related]
14. Treatment outcomes in an integrated civilian and prison MDR-TB treatment program in Russia. Shin SS, Pasechnikov AD, Gelmanova IY, Peremitin GG, Strelis AK, Mishustin S, Barnashov A, Karpeichik Y, Andreev YG, Golubchikova VT, Tonkel TP, Yanova GV, Nikiforov M, Yedilbayev A, Mukherjee JS, Furin JJ, Barry DJ, Farmer PE, Rich ML, Keshavjee S. Int J Tuberc Lung Dis; 2006 Apr; 10(4):402-8. PubMed ID: 16602404 [Abstract] [Full Text] [Related]
15. [The short-term and long-term treatment outcomes in patients with pulmonary tuberculosis positive for drug-resistant and sensitive strains]. Han JP, Sun SL, Li RZ, Zhang FS, Wang SC, Cheng J, Deng YF, Wang Y, Yu CB. Zhonghua Jie He He Hu Xi Za Zhi; 2003 Feb; 26(2):70-3. PubMed ID: 12783654 [Abstract] [Full Text] [Related]
16. [The first-three year report of the Tuberculosis Control Project, Lumbini, Rupandehi]. Masuyama H, Takase A, Aoki M, Shimao T. Kekkaku; 1998 Dec; 73(12):697-703. PubMed ID: 10028803 [Abstract] [Full Text] [Related]
17. [Evaluation of effect of community DOTS on treatment outcomes by TB surveillance data]. Hoshino H, Kobayashi N. Kekkaku; 2006 Oct; 81(10):591-602. PubMed ID: 17094581 [Abstract] [Full Text] [Related]
18. 'Smear-negative' pulmonary tuberculosis in a DOTS programme: poor outcomes in an area of high HIV seroprevalence. Hargreaves NJ, Kadzakumanja O, Whitty CJ, Salaniponi FM, Harries AD, Squire SB. Int J Tuberc Lung Dis; 2001 Sep; 5(9):847-54. PubMed ID: 11573897 [Abstract] [Full Text] [Related]
19. The status and prospects of tuberculosis control in India. Khatri GR, Frieden TR. Int J Tuberc Lung Dis; 2000 Mar; 4(3):193-200. PubMed ID: 10751063 [Abstract] [Full Text] [Related]
20. Rates of drug resistance and risk factor analysis in civilian and prison patients with tuberculosis in Samara Region, Russia. Ruddy M, Balabanova Y, Graham C, Fedorin I, Malomanova N, Elisarova E, Kuznetznov S, Gusarova G, Zakharova S, Melentyev A, Krukova E, Golishevskaya V, Erokhin V, Dorozhkova I, Drobniewski F. Thorax; 2005 Feb; 60(2):130-5. PubMed ID: 15681501 [Abstract] [Full Text] [Related] Page: [Next] [New Search]